65 results
8-K
EX-99.1
TNFA
TNF Pharmaceuticals Inc.
6 Dec 23
Regulation FD Disclosure
9:15am
Exhibit 99.1
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
Company targets first quarter 2024
8-K
EX-99.1
geixyzyxboz2rwm1u0
14 Aug 23
Regulation FD Disclosure
8:30am
8-K
EX-99.1
vyfv2a0 k9uo
3 Aug 23
MyMD Pharmaceuticals Phase 2 Trial Update
4:30pm
424B5
3vl6s0qr0d8rbqrnkf
17 Aug 22
Prospectus supplement for primary offering
3:00pm
8-K
EX-99.1
yf39b vv5n06ekvqst
16 Nov 21
MyMD Pharmaceuticals Receives FDA IND Clearance to Begin Phase 2 Trial of MYMD-1 for Extending Healthy Lifespan
9:25am